Evaluation of a new spike (S) protein based commercial immunoassay for the detection of anti-SARS-CoV-2 IgG

Kirsten Alexandra Eberhardt, Felix Dewald, Eva Heger, Lutz Gieselmann, Kanika Vanshylla, Maike Wirtz, Franziska Kleipass, Wibke Johannis, Philipp Schommers, Henning Gruell, Karl August Brensing, Roman-Ulrich Müller, Max Augustin, Clara Lehmann, Manuel Koch, Florian Klein, Veronica Di Cristanziano
doi: https://doi.org/10.1101/2021.03.10.21253288

Article usage

Article usage: March 2021 to January 2025

AbstractFullPdf
Mar 202197220203
Apr 20212273435
May 20211512430
Jun 20211093223
Jul 20211143520
Aug 20211363019
Sep 2021642129
Oct 2021541928
Nov 2021611123
Dec 20212953
Jan 20223174
Feb 202232611
Mar 20222256
Apr 20222469
May 202221410
Jun 202225565
Jul 202230356
Aug 20222125
Sep 202226810
Oct 20222815
Nov 20221443
Dec 202218510
Jan 20231648
Feb 202319511
Mar 20231073
Apr 20231935
May 20231135
Jun 2023889
Jul 2023614
Aug 202317117
Sep 2023944
Oct 2023834
Nov 202321110
Dec 20231602
Jan 2024813
Feb 202415177
Mar 20241035
Apr 202415116
May 2024672
Jun 202410105
Jul 2024414
Aug 202422613
Sep 20242456
Oct 20241034
Nov 20241217
Dec 202412512
Jan 2025702
Back to top
Posted March 18, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Evaluation of a new spike (S) protein based commercial immunoassay for the detection of anti-SARS-CoV-2 IgG
Kirsten Alexandra Eberhardt, Felix Dewald, Eva Heger, Lutz Gieselmann, Kanika Vanshylla, Maike Wirtz, Franziska Kleipass, Wibke Johannis, Philipp Schommers, Henning Gruell, Karl August Brensing, Roman-Ulrich Müller, Max Augustin, Clara Lehmann, Manuel Koch, Florian Klein, Veronica Di Cristanziano
medRxiv 2021.03.10.21253288; doi: https://doi.org/10.1101/2021.03.10.21253288
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area